103 related articles for article (PubMed ID: 10948346)
1. Selective cytotoxicity of adriamycin immunoconjugate of monoclonal antibody MSN-1 to endometrial adenocarcinoma in vitro and in vivo.
Kaneta Y; Tsukazaki K; Kubushiro K; Sakayori M; Ueda M; Nozawa S
Oncol Rep; 2000; 7(5):1099-106. PubMed ID: 10948346
[TBL] [Abstract][Full Text] [Related]
2. Effect of gelonin immunoconjugate with monoclonal antibody MSN-1 to endometrial adenocarcinoma on antigen-producing tumor cells in vivo.
Kaneta Y; Tsukazaki K; Kubushiro K; Aoki R; Sakayori M; Ueda M; Nozawa S
Jpn J Cancer Res; 1998 May; 89(5):583-8. PubMed ID: 9685864
[TBL] [Abstract][Full Text] [Related]
3. Effects of gelonin immunoconjugate of monoclonal antibody MSN-1 to endometrial adenocarcinoma on antigen-producing tumor cells in vitro.
Kaneta Y; Tsukazaki K; Kubushiro K; Aoki R; Sakayori M; Ueda M; Nozawa S
Oncol Rep; 1997; 4(2):331-6. PubMed ID: 21590053
[TBL] [Abstract][Full Text] [Related]
4. [Characterization of anti human uterine endometrial cancer antibody (MSN-1) and its usefulness in clinical application].
Tsukazaki K; Sakuma Y; Kaneta Y; Sakayori M; Uchiyama M; Nozawa S
Gan To Kagaku Ryoho; 1994 Feb; 21(2):141-9. PubMed ID: 8311483
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of an adriamycin immunoconjugate that recognizes the C-erbB-2 product on breast cancer cell lines.
Jinno H; Ueda M; Enomoto K; Ikeda T; Kyriakos P; Kitajima M
Surg Today; 1996; 26(7):501-7. PubMed ID: 8840431
[TBL] [Abstract][Full Text] [Related]
6. Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker.
Greenfield RS; Kaneko T; Daues A; Edson MA; Fitzgerald KA; Olech LJ; Grattan JA; Spitalny GL; Braslawsky GR
Cancer Res; 1990 Oct; 50(20):6600-7. PubMed ID: 2208122
[TBL] [Abstract][Full Text] [Related]
7. [The antitumor effect of adriamycin conjugated with monoclonal antibody against gastric cancer in vitro and in vivo].
Zhang YT; Wang NQ; Li N; Liu T; Dong ZW
Yao Xue Xue Bao; 1992; 27(5):325-30. PubMed ID: 1442051
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing.
Braslawsky GR; Edson MA; Pearce W; Kaneko T; Greenfield RS
Cancer Res; 1990 Oct; 50(20):6608-14. PubMed ID: 2208123
[TBL] [Abstract][Full Text] [Related]
9. [Importance of the conjugated antibody for the induction of selective effect of adriamycin conjugated with anti AFP monoclonal antibody and entrapped in liposomes against AFP producing tumors].
Konno H; Kumai K; Tsubouchi T; Ishibiki K; Abe O; Tadakuma T; Yasuda T; Nagaike K; Hosokawa S; Sakaguchi S
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2213-7. PubMed ID: 2472119
[TBL] [Abstract][Full Text] [Related]
10. Enhanced tumor cell selectivity of adriamycin-monoclonal antibody conjugate via a poly(ethylene glycol)-based cleavable linker.
Suzawa T; Nagamura S; Saito H; Ohta S; Hanai N; Kanazawa J; Okabe M; Yamasaki M
J Control Release; 2002 Feb; 79(1-3):229-42. PubMed ID: 11853934
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antitumor activity of immunoconjugates prepared by linking 5-fluorouridine to antiadenocarcinoma monoclonal antibody.
Brusa P; Dosio F; Coppo S; Pacchioni D; Arpicco S; Crosasso P; Cattel L
Farmaco; 1997 Feb; 52(2):71-81. PubMed ID: 9181686
[TBL] [Abstract][Full Text] [Related]
12. Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity.
Braslawsky GR; Kadow K; Knipe J; McGoff K; Edson M; Kaneko T; Greenfield RS
Cancer Immunol Immunother; 1991; 33(6):367-74. PubMed ID: 1878890
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor effect of nanospheres coupled with the anti-human liver cancer monoclonal antibody HAb18].
Kan HP; Liu ZJ; Tan YF; Lin YX; Li CF; Zhou J
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1503-5. PubMed ID: 18753092
[TBL] [Abstract][Full Text] [Related]
14. Novel doxorubicin-monoclonal anti-carcinoembryonic antigen antibody immunoconjugate activity in vitro.
Lau A; Bérubé G; Ford CH; Gallant M
Bioorg Med Chem; 1995 Oct; 3(10):1305-12. PubMed ID: 8564396
[TBL] [Abstract][Full Text] [Related]
15. Subcellular localization of blood group Leb carbohydrate antigen (MSN-1-reactive antigen) in endometrial cancer cells.
Susumu N; Kawakami H; Aoki D; Hirano H; Nozawa S
Cancer Res; 1993 Aug; 53(15):3643-8. PubMed ID: 8339270
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines.
Nakanishi O; Baba M; Saito A; Yamashita T; Sato W; Abe H; Fukazawa N; Suzuki T; Sato S; Naito M; Tsuruo T
Oncol Res; 1997; 9(2):61-9. PubMed ID: 9167187
[TBL] [Abstract][Full Text] [Related]
17. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
[TBL] [Abstract][Full Text] [Related]
18. [Production of monoclonal antibody against a newly established human endometrial cancer cell line SNG-II].
Nozawa S; Sakayori M; Takayama Y; Tsukazaki K; Aoki D; Iizuka R; Mukai M; Inaba N
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Apr; 39(4):559-66. PubMed ID: 3295079
[TBL] [Abstract][Full Text] [Related]
19. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin.
Rosenblum MG; Marks JW; Cheung LH
Cancer Chemother Pharmacol; 1999; 44(4):343-8. PubMed ID: 10447583
[TBL] [Abstract][Full Text] [Related]
20. [The mechanism of cytotoxicity of monoclonal antibodies to gynecological cancer cell-lines].
Iida S; Nozawa S
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Jul; 42(7):667-74. PubMed ID: 2212803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]